Advocates for rescheduling psilocybin on the federal list of controlled substances are calling on the federal Drug Enforcement Agency (DEA) to review the drug’s status as a Schedule I substance.
Advocates for rescheduling psilocybin on the federal list of controlled substances are calling on the federal Drug Enforcement Agency (DEA) to review the drug’s status as a Schedule I substance.